|
Market Closed -
Euronext Paris
16:55:00 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.234 EUR | +0.91% |
|
+3.17% | -36.81% |
| 07-24 | Adocia provides a second-quarter update, Stifel still rates it a buy |  |
| 07-23 | Adocia SA Reports Unaudited Revenue Results for Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADOCIA | Bio Therapeutic Drugs | +0.91% | +3.17% | -36.81% | -50.94% | -52.27% | 95.05M |  |  | |
- Stock Market
- Stocks
- ADOC Stock
- Charts Adocia
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
